Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike ...
GlobalData on MSN
Stryker agrees to acquire IVL developer Amplitude Vascular Systems
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.
The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy ...
Apex Securities Research has maintained an "overweight" rating on the Malaysian technology sector, highlighting a significant ...
E2 raises $80M to scale Hēlo®, improving pulmonary embolism treatment with faster, safer, and more efficient procedures.
Gilde Healthcare and Norwest co-led round to commercialize the Hēlo (R) Thrombectomy Platform ...
Medical Device Network on MSN
E2 raises $80m to advance VTE system’s commercialisation
FDA-cleared in December 2025, E2’s Hēlo system is indicated for the non-surgical removal of emboli and thrombi from pulmonary ...
Okami Medical announced that it enrolled the first patient in the ALPHA Registry evaluating its LOBO vascular occlusion ...
California-based medtech E2 (Endovascular Engineering) has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment. | California-based medtech E2 ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results